ZimVie (ZIMV) Competitors $14.04 +0.27 (+1.96%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZIMV vs. INMD, ESTA, BVS, AORT, BLFS, PLSE, MDXG, AVNS, LQDA, and EYEShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include InMode (INMD), Establishment Labs (ESTA), Bioventus (BVS), Artivion (AORT), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), MiMedx Group (MDXG), Avanos Medical (AVNS), Liquidia (LQDA), and National Vision (EYE). These companies are all part of the "medical equipment" industry. ZimVie vs. InMode Establishment Labs Bioventus Artivion BioLife Solutions Pulse Biosciences MiMedx Group Avanos Medical Liquidia National Vision ZimVie (NASDAQ:ZIMV) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking. Does the media refer more to ZIMV or INMD? In the previous week, InMode had 12 more articles in the media than ZimVie. MarketBeat recorded 23 mentions for InMode and 11 mentions for ZimVie. InMode's average media sentiment score of 0.41 beat ZimVie's score of 0.38 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ZimVie 1 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 3 Very Positive mention(s) 4 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, ZIMV or INMD? ZimVie has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Which has stronger valuation & earnings, ZIMV or INMD? InMode has higher revenue and earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimVie$457.43M0.85-$393.28M-$13.11-1.07InMode$492.05M2.95$197.92M$1.859.33 Do institutionals & insiders have more ownership in ZIMV or INMD? 95.6% of ZimVie shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 3.0% of ZimVie shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor ZIMV or INMD? InMode received 157 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 73.73% of users gave InMode an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformZimVieOutperform Votes318.75%Underperform Votes1381.25% InModeOutperform Votes16073.73% Underperform Votes5726.27% Do analysts rate ZIMV or INMD? ZimVie currently has a consensus target price of $18.33, suggesting a potential upside of 30.58%. InMode has a consensus target price of $22.60, suggesting a potential upside of 30.94%. Given InMode's stronger consensus rating and higher possible upside, analysts clearly believe InMode is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZimVie 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00InMode 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is ZIMV or INMD more profitable? InMode has a net margin of 36.26% compared to ZimVie's net margin of -77.31%. InMode's return on equity of 21.04% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets ZimVie-77.31% 2.90% 1.17% InMode 36.26%21.04%18.81% SummaryInMode beats ZimVie on 17 of the 18 factors compared between the two stocks. Ad Timothy SykesHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$387.50M$1.25B$5.39B$8.53BDividend YieldN/A1.49%5.13%4.14%P/E Ratio-1.0730.11113.8115.12Price / Sales0.850.651,483.2593.03Price / Cash2.8611.2639.6434.05Price / Book0.951.174.665.02Net Income-$393.28M-$33.08M$119.06M$225.46M7 Day Performance1.23%0.86%0.79%0.37%1 Month Performance-11.08%-7.27%5.65%3.57%1 Year Performance88.71%15.13%36.76%29.42% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie2.4593 of 5 stars$14.04+2.0%$18.33+30.6%+108.6%$387.50M$457.43M-1.072,600News CoverageINMDInMode3.6174 of 5 stars$17.29+1.2%$22.60+30.7%-9.3%$1.45B$492.05M9.35480Analyst ForecastNews CoverageESTAEstablishment Labs1.9871 of 5 stars$43.09-4.2%$58.83+36.5%+44.0%$1.20B$165.15M-13.86960Upcoming EarningsShort Interest ↑News CoverageBVSBioventus1.7495 of 5 stars$13.76+1.4%$12.00-12.8%+276.2%$1.11B$512.34M-20.851,200Upcoming EarningsAORTArtivion2.038 of 5 stars$26.50+0.6%$30.60+15.5%+107.6%$1.11B$354M-126.191,500Upcoming EarningsNews CoverageBLFSBioLife Solutions1.3246 of 5 stars$23.76+1.5%$26.67+12.2%+135.3%$1.10B$143.27M-14.06409News CoveragePLSEPulse Biosciences1.2205 of 5 stars$17.36-0.4%N/A+232.4%$1.06B$700,000.000.00140Earnings ReportNews CoverageMDXGMiMedx Group4.0174 of 5 stars$7.05+2.9%$12.00+70.2%+7.4%$1.04B$321.48M12.82870Analyst UpgradeAnalyst RevisionNews CoverageAVNSAvanos Medical3.4953 of 5 stars$18.68+0.5%N/A-10.0%$858.35M$673.30M54.943,771News CoverageHigh Trading VolumeLQDALiquidia3.8771 of 5 stars$10.97+1.1%$24.67+124.9%+66.6%$842.39M$17.49M-6.9950Upcoming EarningsEYENational Vision3.6843 of 5 stars$10.47+0.7%$15.25+45.7%-29.4%$823.32M$2.16B-10.1713,998Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies InMode Competitors Establishment Labs Competitors Bioventus Competitors Artivion Competitors BioLife Solutions Competitors Pulse Biosciences Competitors MiMedx Group Competitors Avanos Medical Competitors Liquidia Competitors National Vision Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZIMV) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIMV Stock Alerts